2024
First phase Ⅲ clinical trial Meet Primary Endpoint
2023
B+ round of financing
2022
Clinical milestone
2021
B round of financing
2020
Core team
2019
First IND
2018
A round of financing
2017
XKH004 license-out
2016
Pre-A round of financing
2015
Kanova Biopharma was founded